{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "LARIMAR THERAP.I. DL-,001", "longName": "Larimar Therapeutics, Inc.", "messageBoardId": "finmb_572350487", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 4.74, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 3.2099998, "fiftyTwoWeekLowChangePercent": 2.0980392, "fiftyTwoWeekRange": "1.53 - 6.15", "fiftyTwoWeekHighChange": -1.4100003, "fiftyTwoWeekHighChangePercent": -0.22926834, "fiftyTwoWeekLow": 1.53, "fiftyTwoWeekHigh": 6.15, "earningsTimestamp": 1678791600, "earningsTimestampStart": 1683894600, "earningsTimestampEnd": 1684240200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.34, "sharesOutstanding": 43269200, "bookValue": 2.563, "fiftyDayAverage": 4.6042, "fiftyDayAverageChange": 0.13579988, "fiftyDayAverageChangePercent": 0.029494785, "twoHundredDayAverage": 3.7202, "twoHundredDayAverageChange": 1.0197997, "twoHundredDayAverageChangePercent": 0.27412495, "marketCap": 209125952, "priceToBook": 1.8493952, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 3.4934466, "regularMarketPrice": 4.74, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1591164000000, "priceHint": 4, "regularMarketChange": 0.15999985, "regularMarketTime": 1683871252, "regularMarketDayHigh": 4.74, "regularMarketDayRange": "4.74 - 4.74", "regularMarketDayLow": 4.74, "regularMarketVolume": 50, "regularMarketPreviousClose": 4.58, "bid": 4.54, "ask": 4.7, "symbol": "ZA71.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Three Bala Plaza East", "address2": "Suite 506", "city": "Bala Cynwyd", "state": "PA", "zip": "19004", "country": "United States", "phone": "844 511 9056", "website": "https://www.larimartx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is headquartered in Bala Cynwyd, Pennsylvania.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carole S. Ben-Maimon M.D.", "age": 63, "title": "CEO, Pres & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 845634, "fmt": "845.63k", "longFmt": "845,634"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Celano CPA", "age": 63, "title": "Sec. & CFO", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 562621, "fmt": "562.62k", "longFmt": "562,621"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Berman", "title": "VP of Fin. & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer Spokes Johansson", "title": "VP of Regulatory Affairs & Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nancy M. Ruiz", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gopi  Shankar M.B.A., Ph.D.", "age": 51, "title": "Chief Devel. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Francis Michael Conway CPA", "title": "VP & Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}